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Challenges in Vaccine Communication  




Vaccine communication is a scientifically complex, ethically laden, and highly multidisciplinary area in 
which to conduct research or practice. Due to vaccination’s status as a key topic in public health and 
medicine, communication about vaccination serves as fertile ground for social scientific and critical 
research that can both improve health and help us understand health-related values, mental-models, 
and discourses. This chapter presents background necessary to understand vaccine communication as a 
topic of study, provides an overview of contemporary communication research about vaccines and 
vaccination, and describes frameworks for addressing ethical considerations particular to vaccine 
communication.    
Keywords:  Vaccination, Public Health, Clinical Communication, Mass Communication, Surveillance, 
Ethics 
   
Vaccination is a key topic in public health that highlights the importance of social science-
informed approaches to health communication. Recent waves of vaccine backlash—sometimes fuelled 
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by misinformation (false content) or deliberate disinformation (false content intended to deceive)—
have weakened vaccination levels in communities around the world, increasing risks of vaccine-
preventable disease outbreaks. As a result, there is increased recognition that communication, when 
used effectively, can promote acceptance of vaccination, and that the need for effective vaccine 
communication has never been more urgent. Additionally, the ways people and institutions 
communicate about a topic that is socially contentious despite compelling scientific evidence of its 
benefit may be enlightening to communication scholars, with language and rhetorical devices revealing 
underlying values and connection between these discourses and broader societal trends.   
This chapter will focus on how a communication studies approach can enrich understanding of 
vaccine communication and vaccine promotion efforts. It will discuss ethical considerations particular to 
vaccine communication and call for the integration of communication and information ethics in vaccine 
promotion efforts. Communication and information ethics can offer valuable, critical understanding 
about vaccine communication, and can support efforts to improve rates of vaccine uptake. While 
vaccination is an international concern, and outbreaks of vaccine-preventable disease are increasingly 
global in reach, the current chapter will primarily focus on affluent settings, where infrastructure to 
deliver safe and effective vaccination programs is strong, yet pockets of low confidence threaten 
population vaccine coverage—settings in which communication, persuasion, and trust-building hold the 
potential to overcome many barriers to eradication of vaccine-preventable illness.  
 
Vaccine Communication and Promotion Efforts   
Vaccine Terminology, Discourses and Rhetoric 
A base level of knowledge about vaccination itself is necessary even for communication scholars 
using methods far removed from a clinical setting. Studies of vaccine communication that fail to 
understand vaccinology and medical aspects of vaccination may miss important details relevant to 
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understanding vaccine promotion efforts. Without demonstrated awareness of vaccine science, vaccine 
communication researchers and practitioners are unlikely to be accepted by public health experts as 
credible. Conversely, and of critical importance for this chapter, most applied vaccine promotion efforts 
lack the communication scholar’s insight into the uses of discourse, rhetoric, and other communicative 
techniques that are used by actors in the field to shape vaccination policy and practice.  
Vaccines may be defined as “a type of medicine that trains the body’s immune system so that it 
can fight a disease it has not come into contact with before” (Oxford Vaccines Group, 2019). 
Terminology can be a challenge when describing, or analysing discourses related to, vaccines. For 
example, the term vaccination (giving/receiving a vaccine) is sometimes used interchangeably with 
immunization (the process of acquiring immunity to a pathogen, often following vaccination) 
(Healthdirect Australia, 2019). This choice in terminology may be indicative of deliberate rhetorical 
strategies (e.g., attempting to invoke a positive connotation of immunity rather than the negative 
connotation of injections), or may reveal lack of knowledge, or lack of attention to communicative 
precision. Similarly, most vaccines are given via injection (‘shots’ or ‘jabs’), but some (e.g., rotavirus, oral 
polio vaccine) may be given orally or with a nasal spray (such as the nasal influenza vaccine); however, 
‘shots’ or ‘jabs’ may be casually equated with ‘vaccines’ in everyday practice. Additionally, many 
vaccine-preventable diseases have both a scientific name and a common name (e.g., ‘varicella’ and 
‘chicken pox’), and selection of which terminology to use may also influence vaccine uptake (Cummings 
& Kong, 2019). In applied vaccine promotion such lexical choices are rarely given attention, yet a critical 
reading of the rhetoric of vaccination can reveal an actor’s explicit or implicit agendas and unspoken 
values (e.g., using scientific terms for familiar illnesses to make them sound more serious, or vice versa). 
Vaccines may protect against viruses or bacteria, and may contain weakened versions of a germ 
(‘live’ vaccines), killed (‘inactivated’) versions of a germ, small pieces of a germ, or toxins produced by a 
germ to teach the immune system to recognize and mount a defence against subsequent infection (U.S. 
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National Library of Medicine, 2019). Risks and benefits can vary, making blanket communication of risks 
and benefits of vaccination challenging. In addition to the preventive interventions usually referred to by 
the term vaccines, there now exist targeted ’therapeutic vaccines’, which provoke immune responses in 
efforts to combat a disease or infection the recipient already has (e.g., cancerous tumor, HIV infection), 
and are not deployed on a whole-population basis (Sela & Hilleman, 2004). The scientific complexity and 
sometimes-imprecise use of terminology around vaccination may contribute to lack of clear and 
convincing communication about the risks and benefits of vaccines. 
Despite these challenges, vaccines are considered one of the great successes of modern 
medicine. Two diseases (smallpox in humans and the rinderpest cattle virus) have been eradicated due 
to vaccination, a third (polio) appears close to elimination, and mortality (death) and morbidity (illness 
or disability) due to dozens of other diseases have been greatly reduced (Greenwood, 2014). However, 
structural barriers (e.g., war, poverty, natural disaster) and doubts and concerns about vaccine safety 
and effectiveness contribute to the failure of vaccination campaigns to reach full potential (World 
Health Organization, 2019). While communication has a role to play in terms of improving surveillance 
systems and organizing health services, most vaccine communication research and practice focuses on 
the issue of persuasive communication to overcome vaccine hesitancy.  
 
Vaccine Attitudes 
Vaccine hesitancy, defined as, “delay in acceptance or refusal of vaccination despite availability 
of vaccination services”  (MacDonald & SAGE Working Group on Vaccine Hesitancy, 2015, p. 4161) is a 
key issue of our time, and contributes to undervaccination even in areas with high vaccine access. 
Hesitancy is a concept that has been defined in multiple ways. For example, some definitions of 
hesitancy include anti-vaccine attitudes under a larger ‘hesitancy’ umbrella (MacDonald & SAGE 
Working Group on Vaccine Hesitancy, 2015), while others distinguish between hesitation and outright 
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rejection (e.g., Smith, 2017), or outline a variety of attitudinal stances along a spectrum from 
unquestioning acceptors to complete refusers (e.g., Leask et al., 2012). In some schemas, vaccine 
confidence is positioned as the opposite of hesitancy, whereas in others confidence—or lack thereof—is 
one of the contributors to hesitancy.  
As with language used for vaccines themselves, the language we use to describe and discuss 
vaccine attitudes may carry connotations that lead to greater polarization and undermine efforts to 
improve public understanding about the benefits of vaccines. For example, when vaccine rejectors—or 
anyone other than unquestioning acceptors—are labelled as ‘antivaxxers’, new groups and identities 
may be negotiated, and barriers to communication across identity groups may be clarified or 
entrenched. Some who reject vaccines, or encourage others to do so, embrace the ‘antivax’ label with 
its connotations of resistance and ‘free thinking’, while others assert that they are taking stances that 
are ‘vaccine sceptical’ or ‘pro-vaccine safety’, invoking more scientific or technical labels for what are 
often positions taken in opposition to scientific consensus.  
While it is important not to overattribute vaccine coverage challenges to hesitancy alone—doing 
so risks neglecting real structural barriers1 that persist even in affluent and high-access settings—
understanding and addressing vaccine hesitancy is a challenge many have been tackling in recent years 
(European Centre for Disease Prevention and Control, 2017; Jarrett et al., 2015). Efforts target various 
potential ‘sticking points’ in vaccine delivery including clinician-patient interactions, community 
attitudes, and accessibility of health services. A large portion of these interventions have relied on 
communication research and practical communication strategies. 
 
 
1 Structural barriers are obstacles that disproportionately affect some groups within society, for example: lack of 
parental leave time for child medical appointments, lack of transportation or long travel time to medical care, long 
waits for vaccination appointments, co-payments or fees for vaccinations, health systems that are difficult to 
navigate, and biased healthcare providers who discourage care-seeking.   
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Vaccine Communication Research 
Vaccine communication is a multifaceted, interdisciplinary, and context-sensitive topic drawing 
on a variety of methods and conceptual approaches. Due to the multiple audiences for the knowledge 
generated by studies of vaccine communication, research on this topic is published across disciplinary 
boundaries, spanning clinician-oriented medical journals, public health, information and communication 
studies, sociology and anthropology, and other disciplines and fields. While research on vaccine 
communication is carried out from a variety of disciplinary perspectives, approaches from 
communication and media studies provide valuable insight into how professionals and laypeople 
communicate about vaccines, how vaccine-related messaging might be most effective with specific 
audiences and the importance of using communication in an ethically responsible manner. Even within 
communication studies, approaches draw on a variety of theories and methods, spanning a spectrum 
from highly-applied health communication approaches, which largely draw on quantitative and 
empiricist methods, to those rooted in cultural studies that employ qualitative or humanistic 
approaches.  
Under the broad umbrella of communication and media studies, there is a range of approaches 
to the role of communication in vaccine confidence and hesitancy. Many messaging strategies tested in 
communication research regarding other topics in politics, health, or marketing may be tested 
scientifically for utility in vaccine communication. For example, for senior citizens, narrative approaches 
to vaccine communication have been found to be more effective in shifting attitudes and risk 
perceptions than didactic messaging (Prati et al., 2012). In another example, when attempting to correct 
false beliefs about vaccination, communication research suggests that the use of humour may lead to 
greater persuasive power of the correction (Moyer-Gusé et al., 2018). Message framing research on 
vaccine communication has had mixed results, likely reflecting differences in context and individual 
characteristics. Recent research has focused in on exploring the interplay between framing and factors 
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such as individual psychological and cultural attributes (e.g., Nan, 2012, which found different framings 
to be more effective with young adults with avoidance or approach orientations).  
Cognitive information behaviours and assessment practices are also investigated in studies of 
communication and health. Confirmation bias (selective acceptance of messages that reinforce existing 
beliefs) has been found to play a substantial role in vaccine information assessment and may interact 
with other attributes such as health literacy. For example, Meppelink and colleagues (2019) found an 
association between higher rates of health literacy and stronger confirmation bias, particularly for 
messages that were pro-vaccine, suggesting interrelationships among underlying scientific knowledge, 
confirmation bias, and message acceptance. Related, audience assessments of information appear to be 
affected by a variety of factors including personal characteristics, narrative appeal, scientific credibility 
cues, and trust in source credibility (Haase et al., 2015).  
Finally, research has explored and assessed the influence of health information systems on 
vaccination. For example, immunization information systems, including automated reminders and 
decision-support, now often delivered on mobile apps, may be useful tools for countering 
undervaccination (Gianfredi et al., 2019). Information-based health policies such as vaccine mandates, 
including requirements for school children to provide vaccination records and requirements that parents 
of unvaccinated children attend educational sessions, have been found to show highly context-
dependent and mixed outcomes (Greyson, Vriesema-Magnuson, et al., 2019). The growing utility of big 
datasets for understanding and influencing vaccination, such as identifying internet search terms that 
are predictors of vaccine uptake (Kalichman & Kegler, 2015), is a newer way of drawing on information 
and communications studies to inform vaccine policy and practice.  
 
Vaccine Communication by Healthcare Providers 
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Perhaps the most robust body of communication research on the topic of vaccination is that 
which proposes and tests various approaches to clinical (patient-provider) communication, with an aim 
of improving rates of vaccine uptake. However, this relatively large body of existing research has not 
resolved questions of ideal communication techniques, as the topic is complex, evolving, and highly 
contextual. The majority of this work focuses on how physicians can influence parents’ decision-making 
regarding routine childhood vaccines, and thus tends to be published in medical journals with clinical or 
public health readerships. Studies in this vein may be exploratory, improving understanding of how 
providers and patients do or might best communicate, or confirmatory, testing frameworks or models 
that have been proposed to improve vaccine uptake. Exploratory work on this topic is often survey-
based (Busse et al., 2011; Dubé et al., 2018) or grounded in qualitative interviews and ethnographic 
methods (Kaufman et al., 2019; Poltorak et al., 2005). Findings often lead to development of new 
approaches to vaccine promotion, which may then be tested via confirmatory research. Confirmatory 
clinical communication research often focuses on testing the effectiveness of vaccine communication 
tactics, methods, or approaches. For example a ‘presumptive’ approach (“today your child will be 
getting these vaccines”) has been suggested as successful (in contrast with inviting questions) for the 
majority of parents, most of whom do not have major doubts, concerns, or anti-vaccine attitudes (Opel 
et al., 2013). Whereas presumptive communication methods may lead to higher overall rates of vaccine 
uptake, targeted (customized to a group) and tailored (customized to an individual) educational 
approaches (Schmid et al., 2008) may therefore be necessary for specific populations and individuals 
with low underlying trust.  
The vast majority of vaccine communication research has taken place in affluent nations and 
regions, and the resulting evidence may not be applicable to populations and settings in low- and 
middle-income countries (Lewin et al., 2011). Even in affluent settings, different communication and 
rhetorical techniques may resonate with different subgroups. Wealthy mothers in western ‘gated 
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community’ settings, who are guided by ideologies that emphasize intensive management of ‘unnatural’ 
risks to their children (Reich, 2014), likely require different messages and messengers than Somali 
refugee and immigrant communities who were targeted by anti-vaccine activists taking advantage of 
parents’ fears over high rates of autism diagnoses to promote a false link between vaccination and 
autism (Dyer, 2017). Communicating in a culturally sensitive manner, often by engaging community 
leaders as partners in vaccine communication, has proven effective in building vaccine acceptance. For 
example, a group of Orthodox Jewish nurses in New York formed the Engaging in Medical Education 
with Sensitivity (EMES, meaning “truth” in Hebrew) initiative, and used a variety of methods and media 
(e.g., print materials, living room conversations, women-only vaccine fairs, clinician training) to 
communicate evidence-based vaccine information and teach health literacy skills in their community, 
which was experiencing measles outbreaks exacerbated by alienation from the government and 
healthcare providers from outside the community (Marcus, 2020).  
Clinician-patient communication also involves elements of setting such as timing, medium, and 
the nature of the patient-provider relationship within which communication about vaccines takes place. 
For example, communication aiming to influence new parents’ vaccine decisions for their infants may be 
particularly effective if delivered by obstetric care providers during pregnancy and early postpartum 
(Kaufman et al., 2019), and daily reminders delivered via SMS/text messages may be able to reinforce 
such pro-vaccine messaging during pregnancy (Bushar et al., 2017). For those who provide care to a 
family over many years, such as family doctors and pediatricians, new research is exploring how to build 
longer term relationships of trust that may promote vaccine acceptance; for instance, providing tailored 
information to parents based on their position along the vaccine hesitancy spectrum may optimize 
outcomes by moving quickly to vaccinate those without doubts while allowing time to gently address 
questions of those who are hesitant (Leask et al., 2012).  
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Media Studies and Vaccine Communication 
A second large body of communication research on vaccines is in the area of media studies. 
News media efforts to ‘balance’ pro-vaccine and anti-vaccine perspectives have been explored and 
critiqued as problematic and potentially encouraging vaccine hesitancy. Whereas many journalists have 
positioned pro- and anti-vaccine voices as presenting ‘competing views’ worthy of equal attention, 
vaccine communication researchers argue that balance should focus on the weight of scientific 
evidence, and that not all views carry the same credibility or weight (Clarke et al., 2015). News coverage 
of vaccination and vaccine-preventable disease outbreaks have been the subject of studies exploring risk 
construction and communication, as well as communication of other values such as moral culpability. 
For example, Meyer and colleagues’ (2016) analysis of newspaper coverage of influenza vaccines found 
frequency of risk messaging in newspapers to be positively associated with vaccination rates that year. 
Capurro and colleagues’ (2018) qualitative analysis of the moral framing of vaccines and parents 
opposed to vaccination in news media coverage of the 2014-15 ‘Disneyland outbreak’ of measles found 
that blame was focused on vaccine-refusing parents through the discursive construction of ‘anti-vaxxers’ 
to the extent that it risked stoking moral panic regarding vaccine hesitancy.  
Websites have also been the subject of content and discourse analyses. For example, Grant and 
colleagues’ (2015) study found that websites featuring vaccine skeptical viewpoints were better 
networked and leveraged the affordances of social media to a much greater extent than pro-vaccine 
sites. Website influence on vaccine attitudes has been explored experimentally, as in Betsch et al.’s 
(2010) research that manipulated website content viewed by study participants, resulting in increased 
perception of risks of vaccination after viewing vaccine-critical websites. As the web has become more 
‘social’ and deeply networked, investigations have increasingly explored the potential for social media to 
affect vaccine debates (Witteman & Zikmund-Fisher, 2012). Kata (2012) characterized forms of rhetoric 
common in anti-vaccine social media, but these tactics and tropes may evolve over time and must be 
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revisited periodically. New social media platforms with different affordances and participant populations 
may shape online vaccine communication, as may changes in world events such as the COVID-19 
pandemic, which was accompanied by an ‘infodemic’ of misinformation (World Health Organization, 
2020) that spread rapidly online and converged with anti-vaccine conspiracy networks. Finally, given 
previous findings about the influence of social networks on vaccine attitudes, intervention studies have 
begun to test the potential for social media communication campaigns to promote vaccine acceptance, 
although such experiments have thus far had mixed results  (Daley et al., 2018; Nyhan et al., 2014). 
 
Risk Communication  
The issue of risk communication is a thread running through both interpersonal communication 
and media research on the topic of vaccination. Risk communication is key to many public health issues, 
as well as other topics, including the environment (Muralikrishna & Manickam, 2017; United States 
Environmental Protection Agency, 2015), organizational management (Wiedemann et al., 2011), 
government communication (National Research Council (US) Committee on Risk Perception and 
Communication, 1989), and crisis response (Reynolds & Seeger, 2005; Sandman, 2006). Risk 
communication research encompasses studies of how people and mass media communicate about risks, 
as well as influences on audience risk perceptions and use of risk information (Ruhrmann & Guenther, 
2017). Key issues in risk communication include the social construction and valuation of risk in a given 
cultural context (Lupton, 2014), the gap between expert and layperson understandings of risks 
(Gutteling & Kuttschreuter, 2002; Lazo et al., 2000), and how to communicate in ways that warn the 
public about serious dangers without causing excessive concern over small hazards (Sandman, 2006). 
Risk communication approaches to vaccination draw on multiple disciplinary traditions. Social 
scientific approaches often examine existing risk communication problems to understand social and 
structural factors that shape behaviour. Examples of this might be Petts and Niemeyer’s (2004) UK 
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investigation of strategies parents use to make sense of risks related to the MMR vaccine or Berezin and 
Eads’ (2016) analysis of vaccine risk narratives in U.S. news and trends in non-vaccination. An example of 
a health education approach would be exploring the way the mental models about vaccination held by 
the public shape risk communication needs. Newman and colleagues’ (2009) used this approach in a 
mixed-method study, finding that risk communication for a potential HIV vaccine would need to counter 
fears of vaccine-induced infection and of adverse effects of immunization, as well as temper unrealistic 
expectations of a vaccine as ‘magic bullet’. Public health approaches have ranged from ethical analysis, 
such as Nihlén Fahlquist’s (2018) study of Swedish H1N1 policy around communication of rare adverse 
effects of the pandemic vaccine, to social media analyses of ‘weaponized’ vaccine risk messaging 
(Broniatowski et al., 2018), to clinical trials of the effectiveness of various forms of risk messaging on 
vaccine attitudes and uptake (Fadda et al., 2017; Kasting et al., 2019). Much work in vaccine risk 
communication spans disciplines, or brings together multidisciplinary teams, for example combining 
communication and public health, as in Greenberg and colleagues’ (2017) Canadian national survey of 
parents about vaccine risk beliefs, or politics and pediatrics, such as Nyhan and colleagues’ (2014) study 
of the effectiveness of various web-based MMR vaccine risk messages. Even if not working directly on 
risk communication, communication researchers studying vaccination should be aware of the rich and 
multidisciplinary risk communication literature that underpins a great deal of vaccine communication.  
 
Ethical Frameworks for Vaccine Communication  
Any scholar or practitioner working in vaccine communication should be aware of the great deal 
of ethical deliberation that has gone into vaccination policy and practice. However, much less 
exploration has taken place regarding the ethics of the information systems, communication of vaccine 
science, and vaccine promotion. Much of the ethical consideration about vaccination to date has 
weighed individual autonomy (to decide whether to vaccinate) against the population benefit of 
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achieving high vaccination levels (Dawson, 2011). While cultural norms necessarily influence such 
discussions, these debates largely come out in favour of the good of the population, especially in cases 
of active outbreaks (Giubilini et al., 2018). As public health ethics has increasingly drawn on social 
science perspectives, ethical guidance regarding vaccine promotion interventions—including those using 
communication and information—has become more nuanced.  
Currently, public health ethics and information ethics are beginning to intersect (Greyson, 
Knight, et al., 2019) in ways that can and should inform scholarly inquiry and intervention research on 
topics such as vaccine surveillance and communicative efforts to build vaccine confidence. Of key 
importance is the critical perspective that information and communication scholars bring to the topic of 
surveillance, including the ways surveillance systems and communication efforts can replicate and 
extend systemic biases such as racism when efforts target already-marginalized communities or when 
systems and programs are built on assumptions that are culturally biased.  
 
Information and Communication Ethics 
Information ethics, rooted in library and information science (Hauptman, 1988), has focused on 
issues including censorship and intellectual freedom, intellectual property rights, public access to 
information, privacy and security, and digital governance (Burgess et al., 2019; Moore, 2005). The 
concerns of information ethicists are highly germane to vaccine communication. These concerns include 
access to medical research and issues of medical privacy, including development of a “surveillance 
society” (Lyon, 1994) in which everyday surveillance is normalized and serves to entrench existing social 
hierarchies. Examples of normalized surveillance causing public health problems include predictive 
policing algorithms that have been found to intensify levels of over-policing and police violence against 
Black individuals and communities (Heaven, 2020) and breaches in the confidentiality of personal health 
data leading to stigma and inequities (Lyerla & Stroup, 2018). Communication ethics hasn’t developed a 
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unique body of literature distinct from information ethics as a whole, and formal statements of 
communication ethics tend to affirm the importance of transparency, truthfulness, freedom of 
expression, and other principles commonly included in information ethics (see, for example, National 
Communication Association, 2017).  
 
Public Health Communication Ethics  
Public health ethics has expanded upon the focus of traditional western biomedical ethics on 
the principles of autonomy, beneficence, non-maleficence, and justice in clinical practice (Beauchamp & 
Childress, 2013), by also considering issues of individual and population welfare, interventions launched 
for the good of the public, and multi-agency efforts to intervene in social and structural causes of health 
or illness (Dawson & Verweij, 2008; Holland, 2007). A subset of public health interventions use 
information, either in the form of communications, surveillance, or bidirectional programs that combine 
communication and surveillance together, and these information interventions carry their own risks and 
complexities that should not be dismissed (Greyson, Knight, et al., 2019). 
A small body of research and theory has emerged focused on the ethics of public health 
communication, and in particular unintended consequences of health communication efforts. Guttman 
(1997), for example, identified ethical concerns within health communication campaigns, including 
issues of misleading content, coercive messaging, targeted messages serving to stigmatize groups, and 
dilemmas related to harm reduction approaches. Efforts to discourage unhealthy behaviours also run 
the risk of stigmatizing those who are already-ill or creating the impression that certain groups are 
destined to be unhealthy (see, for example, Frohlich et al., 2012 on the war on smoking’s creation of the 
socially marginalized youth smoker). Additionally, health promotion messages might raise ethical 
concerns when they reinforce stereotypes as part of an effort to reach members of traditional cultural 
communities, or objectify women in an effort to attract attention to women’s health (Guttman & 
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Salmon, 2004). While advertising techniques are commonly applied in public health messaging, and may 
in fact produce positive population health outcomes (e.g., reduction in risky behaviours), ethical 
considerations arise when such persuasive messaging overrides fully informed consent, acting too 
strongly to ‘sell’ a particular behavior or intervention without adequate disclosure of full risk and benefit 
information.  
In contrast to critical perspectives on surveillance, which are common in communication and 
media studies, surveillance has been relied upon as the ‘cornerstone’ of public health (Lee & Thacker, 
2011). Collection and analysis of epidemiological data is key to monitoring outbreaks of disease as well 
as identifying risk factors for individuals and communities, and public health has made inroads into 
harnessing the power of geospatial mapping and ‘big’ data such as real-time internet search metrics to 
identify, predict, and address health threats. However, prominent voices in public health ethics have 
also raised concerns over risks of surveillance, particularly when it contains personally-identifiable data 
or addresses stigmatized health conditions such as HIV (Fairchild & Bayer, 2011). Similarly, data sharing 
between, for example, public health and law enforcement, raises ethical concerns even if it carries the 
potential to improve health or curtail outbreaks, and targeted surveillance of particular groups (e.g., 
Indigenous communities, poor neighbourhoods) may serve to compound stigma and marginalization 
(Fairchild & Bayer, 2004). 
 
Ethical Considerations for Vaccine Communication  
Vaccine communication research and practice may be viewed through lenses of both 
information and communication ethics, and public health ethics. Particularly when considering 
interventions that involve surveillance, the incorporation of both ethical traditions enables 
consideration of the potential value of granular data and the risks for privacy and stigmatization that 
may accompany population surveillance. As new digital technologies are increasingly drawn upon in 
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vaccine communication, for example, through mobile vaccine reminder and record-keeping apps, such 
concerns may grow.  
High quality communication can minimize ethical risks regarding vaccination by presenting 
information in ways appropriate for a given audience, and by partnering with trusted community leaders 
to deliver evidence-based messages and to conduct surveillance of vaccine coverage in culturally 
acceptable ways. However, skilled communication techniques may also be used in unethical ways such 
as by leveraging existing online trust networks to perpetuate disinformation about vaccine safety. 
Additionally, low-quality communication (e.g., without reference to sources, or using misleading ‘scare’ 
statistics and graphs with inappropriately truncated axes) can serve as fuel for anti-vaccine campaigns, 
even if intended to encourage better population health outcomes.  
One example of poor risk communication that can be experienced by the public as manipulative 
is the risk of Guillain-Barré Syndrome (GBS) following influenza vaccination. GBS is a rare syndrome that 
causes nerve damage and paralysis, often following an infection. A slightly heightened risk of GBS has 
been associated with receipt of some years’ influenza vaccines, although that risk is much smaller than 
the risk following influenza disease (Centers for Disease Control and Prevention, 2020). Statistics such as 
“one GBS admissions per million vaccinations compared with 17 GBS admissions per million influenza 
infections” (The Children’s Hospital of Philadelphia, 2018, para. 1) are commonly used in efforts to 
persuade individuals to receive the influenza vaccine, without factoring in how likely a person is to 
experience influenza disease in a given year. While the math would still come out in favor of vaccination, 
both on individual and population levels, presenting these statistics as comparable when they do not 
have common denominators can erode trust and reinforce hesitancy. When public health and clinical 
communication fail to fill gaps in public understanding (such as how likely one is to experience GBS in a 
given year with versus without influenza vaccination), this provides opportunities for disinformation 
peddlers to scare and misinform people.  
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Even commonly accepted terminology, such as ‘vaccine preventable disease’ or ‘vaccine 
hesitancy’ can carry and convey multiple meanings and be invoked and interpreted in accordance with 
multiple, sometimes competing discourses. For example, to someone unconvinced about a given 
vaccine because it is only 88% effective, calling the disease ‘vaccine preventable’ may sound 
disingenuous, as the vaccine does not guarantee prevention to the individual receiving the vaccine. 
Public health understanding is focused on the whole population, however, and if the entire population is 
vaccinated at a high level, that 88% effectiveness is considered sufficient to prevent disease outbreaks—
in other words, if one case is introduced from elsewhere, it would be prevented from spreading 
throughout the community.  
While these examples are common in vaccine promotion, a trained communication professional 
who has studied the ways communication and discourses shape hesitancy about vaccination is well-
equipped to identify them from a perspective unique to that of most health professionals. Further, a 
scholar of communication ethics will be prepared to help those working in public health act in ways that 
are neither manipulative, stigmatizing, nor needlessly invasive, ultimately improving public trust in 
vaccine communication from authoritative scientific sources.  
 
Conclusion 
Vaccine communication is a scientifically complex, multidisciplinary, and ethically laden area in 
which to conduct research or practice. The language used to communicate about vaccination contain 
key information about the values, beliefs, and mental models held by individuals, organizations, and 
populations, and hold the potential to improve health globally. Vaccine communication also has 
important ethical dimensions, and both academic and professional discourse about vaccination 
increasingly demands that we align information ethics and public health ethics approaches, in order to 
improve vaccine communication knowledge and practice.  
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Similar to many health communication topics, vaccination is both technically challenging and 
culturally sensitive. While vaccination is a core strategy for the health of populations, best practices for 
communication about vaccines remain a work in progress. Given the context-dependence of both 
infectious disease and health decision-making, vaccine communication is a topic for which 
interdisciplinary collaboration and academic cross-pollination is imperative. Drawing on both sound 
vaccine science and communication studies perspectives on effective message framing, audience 
reception, context-specific values around risk perception, and interpersonal communication dynamics 
provides the most promise for improving the vaccine communication landscape today.   
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